CareCloud, Inc.
NASDAQ:CCLD · NASDAQ Global Market
-$0.02 today
Vol 0.44M · Avg 0.66M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:CCLD · Revenue to Net Income
Key Ratios
Analysis
$124.1M of revenue converted into $9.8M of net income for the selected period. Gross margin is 32.9% and net margin is 7.9%, showing how much revenue survives after costs and taxes. EPS is $0.11, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $120.5M +8.7% | $110.8M -5.3% | $117.1M -15.7% | $138.8M -0.6% | $139.6M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $64.5M +5.9% | $60.8M -14.1% | $70.8M -16.1% | $84.4M -2.9% | $86.9M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $56.0M +12.1% | $50.0M +8.1% | $46.2M -15.0% | $54.4M +3.2% | $52.7M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 46.5% +1.4pp | 45.1% +5.6pp | 39.5% +0.3pp | 39.2% +1.4pp | 37.7% | 9.8% | 28.9% | 38.3% |
| Research & Development | $6.4M +68.8% | $3.8M -20.2% | $4.7M +7.6% | $4.4M -0.2% | $4.4M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $23.2M +3.8% | $22.4M -28.2% | $31.1M -7.4% | $33.6M +1.7% | $33.1M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $44.5M +9.0% | $40.9M -56.2% | $93.4M +95.4% | $47.8M -2.8% | $49.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $17.0M +5.2% | $16.1M -2.5% | $16.6M +10.3% | $15.0M -7.6% | $16.3M | $374.2M | $1.2B | $631.8M |
| EBITDA | $28.3M +12.8% | $25.0M +180.0% | -$31.3M -248.8% | $21.0M +6.7% | $19.7M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 23.5% +0.9pp | 22.6% +49.3pp | -26.7% -41.9pp | 15.1% +1.0pp | 14.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $11.5M +26.0% | $9.1M +119.4% | -$47.1M -812.8% | $6.6M +87.3% | $3.5M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 9.5% +1.3pp | 8.2% +48.5pp | -40.2% -45.0pp | 4.8% +2.2pp | 2.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $206.0K +134.1% | $88.0K -42.9% | $154.0K +275.6% | $41.0K +173.3% | $15.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $287.0K -68.1% | $900.0K -24.6% | $1.2M +194.8% | $405.0K -11.0% | $455.0K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$500.0K +55.0% | -$1.1M +42.3% | -$1.9M -92.1% | -$1.0M -86.8% | -$536.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $11.0M +37.3% | $8.0M +116.3% | -$49.0M -974.3% | $5.6M +87.4% | $3.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 9.1% +1.9pp | 7.2% +49.1pp | -41.9% -45.9pp | 4.0% +1.9pp | 2.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $199.0K +24.4% | $160.0K +144.0% | -$364.0K -305.6% | $177.0K +12.7% | $157.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | $10.8M +37.5% | $7.9M +116.1% | -$48.7M -996.1% | $5.4M +91.5% | $2.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | 9.0% +1.9pp | 7.1% +48.7pp | -41.6% -45.5pp | 3.9% +1.9pp | 2.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $0 +135.7% | -$0 +93.2% | -$4 -513.4% | -$1 +13.0% | -$1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $0 +135.7% | -$0 +93.2% | -$4 -513.4% | -$1 +13.0% | -$1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $377.9M +2240.5% | $16.1M +3.0% | $15.7M +3.7% | $15.1M +3.9% | $14.5M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $379.5M +2250.5% | $16.1M +3.0% | $15.7M +3.7% | $15.1M +3.9% | $14.5M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$328.84M

Apyx Medical Corporation
NASDAQ:APYX
$196.39M
Turn Therapeutics Inc.
NASDAQ:TTRX
$180.07M

TuHURA Biosciences, Inc.
NASDAQ:HURA
$147.74M

Agenus Inc.
NASDAQ:AGEN
$137.42M

The Joint Corp.
NASDAQ:JYNT
$136.57M

Lucid Diagnostics Inc.
NASDAQ:LUCD
$98.28M

Seer, Inc.
NASDAQ:SEER
$94.57M

Rapid Micro Biosystems, Inc.
NASDAQ:RPID
$79.77M
VSee Health, Inc.
VSEE
$2.31M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does CCLD generate?
CareCloud, Inc. (CCLD) reported $120.50M of revenue in fiscal 2025.
Is CCLD profitable?
CareCloud, Inc. (CCLD) reported $10.80M of net income, with a net margin of 9.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.